News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mirna Therapeutics, Inc. Appoints Casi Deyoung As Chief Business Officer


3/19/2014 7:19:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mirna Therapeutics (Mirna), a private, clinical stage biopharmaceutical company focused on the development of microRNA-based oncology therapeutics, today announced Casi DeYoung has joined the company as chief business officer. Ms. DeYoung will be responsible for the company’s corporate development and business development efforts, including planning and execution of strategic growth initiatives and external partnerships.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES